Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis Sativa, has
garnered increasing attention for its diverse therapeutic potential. This comprehensive …

Perfluorooctanesulfonic acid (PFOS), a fluorine-containing organic compound, can be
widely detected in the environment and living organisms. Accumulating evidence has shown …

Substance use is common among those with heart failure (HF) and is associated with worse
clinical outcomes. Alcohol, tobacco, cannabis, and cocaine are commonly abused …

The number of lipophilic drug candidates in pharmaceutical discovery pipelines has
increased in recent years. These drugs often possess physicochemical properties that result …

Mitochondrial dysfunction has been suggested to be the key factor in the development and
progression of cardiac hypertrophy. The onset of mitochondrial dysfunction and the …

The commercialization of products with cannabidiol (CBD) has undergone a significant
increase. These products can be presented in different forms such as baked goods …

Cardiovascular disease (CVD) causes millions of deaths worldwide each year. Despite the
great progress in therapies available for patients with CVD, some limitations, including drug …

Trema, a genus of the popularly known Cannabaceae, has recently been the subject of
cannabinoid bioprospection. T. micrantha is a tree with pharmacological potential widely …

Background There is a worldwide interest in the use of Cannabis sativa for biomedicine
purposes. Cannabis has ethnomedicinal usage as a natural medicine in Bangladesh and …

The study explored the potential protective influence of cannabidiol (CBD) on myocardial
inflammation state, with a special focus on arachidonic acid (AA), and oxidative balance in …